Regnante Keith's Form 4 filing
Keros Therapeutics, Inc. (KROS) · filed Jan 8, 2024
- Accession no.
- 0001209191-24-001155
- Filed
- Jan 8, 2024
- Trade date
- Nov 4, 2023-Jan 4, 2024
- Filing delay
- 65 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.81M. It was filed 65 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0001415889-25-002024 (Jan 24, 2025). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Regnante KeithCIK 0001682068 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2023 | Common Stock | MOption exerciseAcquired | +40,000 | $16.00 | +$640,000 | 40,000 | Direct | |
| Nov 4, 2023 | Common Stock | SSaleDisposed | −40,000 | $45.29 | −$1,811,600 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | Common Stock | MOption exerciseDisposed | −40,000 | $0.00 | $0 | 53,622 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.